TMU x BE x SCHS Demo Day : Bridge to Beyond

技術已成熟，卻始終難以跨過臨床驗證這道門檻？產品準備就緒，卻還在尋找資金與進軍國際市場的切入點？與台灣醫療創新最強陣容 TMUxBExSCHS 現場交流，探索醫療創新實現的關鍵下一步！

在醫療創業的關鍵轉折上，臨床、資本與市場的串連往往是最難跨越的鴻溝。每一位創業者都需要一座穩固的橋樑，連接醫師信任、投資人肯定，與產品真正落地應用的可能。

全台唯一生醫新創DemoDay由比翼生醫、台北醫學大學生醫加速器與秀傳醫療體系共同主辦，攜手打造一座橫跨技術創新、臨床驗證、資本連結與國際拓展的實戰平台。邀集來自全球的醫療新創團隊、臨床專家與投資人齊聚一堂，一起推動醫療創新持續走向國際。誠摯邀請您一同參與，共同見證未來醫療創新的進化軌跡！

【活動資訊】

▸活動名稱：TMU x BE x SCHS Demo Day: Bridge to Beyond

▸活動日期：2025.7.25 Fri.

▸活動時間：12:30-16:30

▸活動地點：南港展覽館1館 504會議室（台北市南港區經貿二路1號）

【活動亮點】

✨亞洲唯一直通醫院的臨床導向 Demo Day：攜手醫療體系，幫助新創實測技術、加速落地。

✨16 組國際醫療新創團隊登場：聚焦 AI 診斷、智慧照護與精準醫學，涵蓋 9 國市場與臨床挑戰。

✨國際級專家對談 Panel：由 David Uffer 領航，深談資本與臨床如何攜手擴張醫療創新。

無論您是投資人、創業者，還是醫療科技實務專家，這場聚焦臨床驗證與全球市場的 Demo Day 將帶來深度交流與真實機會。立即報名，搶先掌握下一波醫療創新勢力！

Your technology is ready and your product is built—but are you still struggling to break into clinical validation, secure funding, or access global markets?

Meet Taiwan’s top medical innovators — TMUxBExSCHS — and discover what’s next in healthcare innovation!

In medtech innovation, bridging clinical adoption, investor confidence, and real-world market entry is one of the toughest challenges. Every founder needs a strong bridge—connecting clinical trust, capital readiness, and actual deployment in the field.

Jointly hosted by BE Health, Taipei Medical University Biomed Accelerator, and Show Chwan Healthcare System, this is Taiwan’s only MedTech DemoDay focused on clinical validation.
This year’s theme, “Bridge to Beyond,” builds on our mission to accelerate MedTech innovation through clinical collaboration, investor connections, and international expansion.
We invite healthcare startups, clinicians, and investors from around the world to join us in advancing the next wave of global medical innovation.

[Information]

▸ Event Name: TMU x BE x SCHS Demo Day: Bridge to Beyond

▸ Date: July 25, 2025

▸ Time: 12:30-16:30 (Taiwan Time)

▸ Venue: Nangang Exhibition Center Hall 1, Room 504 (No. 1, Jingmao 2nd Rd., Nangang District, Taipei)

[Highlights]

✨Asia’s only hospital-integrated, clinically-driven Demo Day:
In partnership with medical institutions, startups get real-world testing and clinical feedback to accelerate adoption.

✨16 global startups across 9 countries:
Showcasing innovations in AI diagnostics, smart care, and precision medicine, tackling both technical and clinical challenges.

✨Expert panel discussion:
Led by MedTech strategist David Uffer, exploring how capital and clinical validation converge to scale medical innovation.

【Startups】

【Panel Discussion】

❏ Topic: Capital Meets Clinical: How MedTech is Scaling in a Rebounding Market 醫療科技如何在復甦市場中擴張突圍

✦Moderator: 

✧David Uffer｜Managing Director, Trinity Life Sciences

David Uffer 擁有超過 25 年醫療科技、診斷與數位健康領域的全球經驗，現任 Trinity Life Sciences 的 Managing Director。曾主導 General Inception 的 MedTech 投資組合，並參與 Medtronic、Hologic、Boston Scientific 的併購與投資案，專長於協助企業制定成長策略、進入市場並推動商業化，能引導早期團隊釐清產品價值、規劃臨床進程，並拓展投資與國際合作機會，加速產品走向全球市場。

David Uffer brings over 25 years of global experience in MedTech, diagnostics, and digital health. As Managing Director at Trinity Life Sciences, he has led MedTech investment portfolios at General Inception and played key roles in M&A and strategic investments with major healthcare companies including Medtronic, Hologic, and Boston Scientific. He specializes in guiding early-stage teams to define product value, plan clinical pathways, and accelerate commercialization through strategic growth, partnerships, and global market expansion.

✦Panelist:

✧Nobuhiro Yagi｜Executive Officer, Head of Investment Dept I, Kyoto University Innovation Capital

Nobuhiro Yagi 專注於深科技與大學技術的創投投資，現於京都大學創投公司管理超過 340 億日圓資產，協助新創從研究孵化走向全球市場。他橫跨學術、產業與政府機構；代表性投資組合包括核融合技術公司 Kyoto Fusioneering、mRNA 新創 aceRNA Technologies、癌症免疫學公司 BTB Therapeutics，以及 LegalTech 獨角獸 LegalOn Technologies。

Nobuhiro Yagi focuses on deep tech and university-originated innovation investments. He currently manages over JPY 34 billion in assets at Kyoto University Innovation Capital, helping startups transition from research to global scale-up. With a background spanning academia, industry, and government, his notable portfolio includes Kyoto Fusioneering (nuclear fusion), aceRNA Technologies (next-gen mRNA), BTB Therapeutics (cancer immunology), and LegalOn Technologies (LegalTech unicorn).

✧ Pei-Jing Kao｜台灣證券交易所 組長

台灣證券交易所為亞洲最具代表性的交易所之一，持續吸引國際企業赴台上市，強化區域資本動能；現任台灣證券交易所上市二部組長，擁有超過 15 年資本市場實務經驗，專責推動境外企業來台掛牌與國際接軌。

The Taiwan Stock Exchange (TWSE) is one of the most prominent exchanges in Asia, continuously attracting international companies to list in Taiwan and strengthening regional capital momentum. Currently serving as the Section Chief of the Listing Department II at TWSE, she brings over 15 years of hands-on experience in capital markets, specializing in facilitating the listing of foreign companies in Taiwan and advancing international alignment.

✧ Natalie Torin｜Partner, Woods Capital

擁有豐富家族辦公室顧問與跨境投資經驗，現任 Woods Capital 合夥人，聚焦房地產、永續與教育等領域的國際創新布局。亦為 GrayBella Capital 資深顧問，曾任職於 US Capital Global，並創辦女性商業導師社群 Natalie’s Network，致力於推動女性領導力發展。

Natalie Torin is a seasoned advisor to family offices and cross-border investors. As Partner at Woods Capital, she focuses on international investments in real estate, sustainability, and education. She also serves as a senior advisor at GrayBella Capital, was previously with US Capital Global, and founded Natalie’s Network — a global platform supporting women’s leadership and mentorship in business.

【Organizers】

➣臺北醫學大學 TMU BioMed Accelerator

臺灣首家國際級創新醫療大學加速器，專注於「數位醫療」、「人工智慧」、與「醫療器材」三大主題，整合臺北醫學大學完善的醫療臨床體系資源，協助新創臨床試驗規劃並建立醫療通路、商業模式、創業資金募集、新創社群與國際資源的鏈結、輔導團隊降低產品開發風險，並善用北醫完善的醫療臨床場域與專業醫師，導入北醫大數據處，包含臨床資料庫、健保資料庫、臨床數據中心等，提供優質的數據服務，以及北醫大人體研究處，輔導新創團隊產品臨床試驗的研發策略，使新創團隊加速研究成果商品化並鏈結國際生態圈。

Taiwan's first international innovative medical university accelerator, with a well-established medical market, clinical resources, biomedical and artificial intelligence talents. TMU focus on three themes of "digital medicine", "artificial intelligence" and "medical equipment", assisting startups in fundraising, linking new communities with international resources, reducing product development risks, establishing medical pathways with clinical trials. TMU leverage the expertise of our physicians, to guide the team's products in clinical trials, so as to accelerate the commercialization of research results and link the international ecosystem.

➣比翼生醫 BE Health

比翼生醫（BE Health）是一家專注於投資創新醫療科技的「醫院創投」，同時也是台灣最大的醫療生技新創加速器。自2018年成立以來，已輔導100+具影響力且前瞻性的新創團隊，並協助其籌得超過1.5億美元資金。我們專注於創新醫材與數位醫療領域，運用台灣為全球醫療新創進入亞洲市場的橋樑，與全球重量級醫療體系、研究機構、投資者和生技專家夥伴緊密合作，於嚴峻棘手的醫療領域建構國際生態系統，共同努力協助新創成長為顛覆性企業。我們的使命為與生態系的夥伴協力培育優秀的醫療新創團隊，推動創新醫療科技，提供患者更好的醫療體驗。

BE Health is a "hospital VC" dedicated to investing in innovative medical technology. It is also the largest medtech and healthtech startup accelerator in Taiwan. Since our establishment in 2018, BE Health has mentored over 100 influential and forward-thinking startup teams, helping them raise over $150 million in funding. We focus on innovative medical devices and digital healthcare, utilizing Taiwan as a gateway for global medical startups to enter the Asian market. We work closely with prestigious healthcare systems, research institutions, investors, and biotech experts worldwide to build an international ecosystem in the challenging and complex field of healthcare. We work together to assist startups in their growth journey, aiming to transform them into disruptive enterprises. Our mission is to collaborate with ecosystem partners in nurturing exceptional medical startup teams and driving innovative medical technology to provide patients with better healthcare experience.

➣台灣秀傳醫療體系Show Chwan Healthcare System

秀傳是臺灣目前最大的的私人醫療集團，在全台擁有9家醫院、3,700張床位與6,000名員工。由黃明和總裁自1973年創立以來，使命即期望將領先的技術和服務提供至資源不足的地區。且除了三級醫療服務之外，同時也有針對老年人、產婦保健和綜合癌症護理設施。

Show Chwan is a hand-in-hand “family” healthcare system with a current number of 9 hospitals, 3700 beds, and 6000 employees. For medical and healthcare, President Huang Min-Ho advocates the spirit of “Mayo Clinic” by establishing a “sound rural hospital” system, allowing even the people in the most remote of areas to enjoy the quality and cordial medical care found in cosmopolitan cities. Apart from that, SCMH also has care facility targeting elderly, postnatal care and cancers.

➣秀傳亞洲遠距微創手術訓練中心 IRCAD-Taiwan

IRCAD遠距微創手術中心1994年於法國史特拉斯堡發跡，結合最先進的科技與享譽國際的專家學者，致力於培育訓練外科醫師。因著秀傳醫療體系與法國遠距微創手術中心的合作，亞洲遠距微創手術中心於2008年落成，延續法國微創中心的努力，為亞洲的外科醫師帶來最好的教育訓練模式。目前已經受訓國內外來自68國、總額超過21,913參與者。師承自法國微創中心的外科訓練模式，一步步的手術示範教學、活體豬隻與大體實驗操作，為亞洲的外科醫師帶來最好的教育品質。

IRCAD, which originated in Strasbourg, France in 1994, combines cutting-edge technology with renowned experts and scholars, dedicated to cultivating and training surgeons. Through collaboration with the Show Chwan Healthcare System, Asian Institute of Telesurgery (AITS/IRCAD-Taiwan) was established in 2008, continuing the efforts of the French Minimally Invasive Surgery Center to provide the best educational and training model for Asian surgeons. Currently, it has trained over 21,913 participants from 68 countries worldwide. Following the surgical training model of the French Minimally Invasive Surgery Center, step-by-step surgical demonstrations, live animal and cadaver experiments bring the highest quality of education to Asian surgeons.

【Agenda】